- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
RXi Pharmaceuticals Corp+ Add to Watchlist
RXII:US0.7287 USD 0.0037 0.51%
As of 20:10:00 ET on 04/20/2015.
Company Profile for RXi Pharmaceuticals Corp (RXII)
RXi Pharmaceuticals Corp. is a biotechnology company focused on discovering, developing and commercializing therapies addressing major unmet medical needs using RNAi-targeted technologies. The Company's proprietary RNA interference ("RNAi"), is a naturally occurring cellular mechanism that interferes with or silences expression of targeted disease-associated genes.
RXi Pharmaceuticals Corp
Key Executives for RXi Pharmaceuticals Corp (RXII)
|Geert CauwenberghPresident/CEO/Acting CFO||Pamela A PavcoChief Development Officer|